Background: Despite the current evidence of preventive screening effectiveness, rates of breast, cervical, and colorectal cancer in the United States fall below national targets. We evaluated the efficacy and feasibility of combining practice facilitation and academic detailing quality improvement (QI) strategies to help primary care practices increase breast, cervical, and colorectal cancer screening among patients.
tests, flexible sigmoidoscopy, and colonoscopy; breast cancer screening through mammography; and cervical cancer screening through Papanicolaou tests have been identified by the US Preventive Services Task Force (USPSTF) as effective preventive measures for the early identification of CRC, breast cancer, and cervical cancer. 2 However, rates of screening for these cancers remain below the national Healthy People 2020 targets in the United States. 3 In addition, large segments of the population (including the uninsured, rural residents, Hispanics/Latinos, African Americans, Native Americans, and those with low education levels and low socioeconomic status) have been shown to be significantly less likely to receive appropriate cancer screening and will likely experience a higher burden of cancer because of suboptimal screening. 4 -9 A variety of factors present challenges to the effective provision of cancer screening in primary care, including numerous guideline recommendations, patient reluctance or refusal, and resource constraints. 10 -13 Primary care practices can benefit from interventions and techniques to address barriers to the effective provision of population health maintenance services, including cancer screening. One potential intervention to achieve this goal is the use of practice facilitation and academic detailing.
Practice facilitation involves the work of trained quality improvement (QI) professionals who assist primary care practices in research and QI activities. 14 -16 Assistance includes data collection, feedback on provider and practice performance, and the facilitation of systems-level changes to improve practice processes. Academic detailing is modeled based on the communication approach of pharmaceutical industry detailers and involves trained experts visiting health care professionals in their own setting to provide tailored education on specific health topics and evidence-based guidance on best practices. [17] [18] [19] The goal of combined practice facilitation and academic detailing is to help primary care practices align their work with evidence-based best practices to improve patient care and outcomes. 14, 20 The purpose of the project detailed in this article was to evaluate the efficacy and feasibility of combining practice facilitation and academic detailing to help primary care practices increase patient breast cancer, cervical cancer, and CRC screening in 3 regional practice-based research networks (PBRNs) in Central and Western New York: the Studying-Acting-Learning-Teaching Network (Syracuse, NY), the Upstate New York PBRN (Buffalo, NY), and the Greater Rochester PBRN (Rochester, NY). This evaluation investigated the impact of this grant-funded intervention on cancer screening rates, as well as how components of the intervention were implemented across varying practice structures.
Methods

Practice Facilitation and Academic Detailing Intervention
Primary care practices were recruited for enrollment based on their capacity to affect a high percentage of patients among the following populations: racial/ethnic minorities, those with low socioeconomic status, the uninsured, those from geographically isolated/rural locations, and Medicaid-eligible populations. Twenty-seven practices were approached for enrollment, all of which had established relationships with 1 of the 3 participating regional PBRNs.
Physicians, nurses, and other care providers at each practice received a 1-hour, continuing medical education-accredited academic detailing session (ADS) presented by a primary care physician with expertise in cancer prevention recommendations. After completing the ADS, enrolled practices received a minimum of 6 months of practice facilitation services provided by 1 of 4 trained practice facilitators (PFs) from 2014 to 2015. The intervention period was limited to 6 months because of the 1-year funding cycle of the project. All PFs had formal training in QI coaching in the health care setting, with a minimum of 2 years' experience in the field. The focus of the practice facilitation intervention targeted evidence-based strategies to increase breast cancer, cervical cancer, and CRC screening (identified through the Centers for Dis-ease Control and Prevention's Community Guide to Preventive Services 21 ), as well as improvements related to electronic health record (EHR) data.
PFs met with key personnel at each practice, including medical directors, practice managers, and other clinical staff, to review current office workflows and policies, as well as clinic performance in cancer screening. Each practice was afforded flexibility in determining their specific interventions to accommodate differences in practice size, location, administrative structure, and performance priorities. Selected interventions were required to be considered evidence-based, as determined by the benchmarks established in the Centers for Disease Control and Prevention's Community Guide to Preventive Services. The project team leadership and the program officer of the funder jointly reviewed all interventions to ensure each met evidence-based criteria.
Data Collection and Analysis
Changes in Screening Rates
Practices reported the aggregated number of all current patients within the eligible screening population (denominator) and the number of current patients who had received appropriate screening for breast cancer, cervical cancer, or CRC (numerator), according to the most recent screening guidelines from the USPSTF and/or the American Cancer Society, at both the initiation and conclusion of the 6-month practice facilitation period. Practices chose to follow the guideline of their choice based on provider preferences and reporting procedures in effect at the time of project initiation. These numbers were used to calculate a practicelevel measure of the proportion of patients who had received appropriate screening, as documented in the practice EHR, for each practice both before and after the intervention. The criteria used to define current patients generally consisted of patients seen at least once within the past 1 to 3 years, depending on practice protocols. Comparisons between cancer screening rates before and after the intervention were evaluated using 1-way repeated measures analysis of variance (ANOVA).
Changes in Practice Staff Attitudes and Experiences
Surveys were administered to clinical care team staff (physicians, nurses, care coordinators) and office administrative staff working at each practice; the PFs administered the surveys directly following the ADS and again at the close of the 6-month practice facilitation period. The surveys collected anonymous demographic information and responses to questions regarding respondent attitudes and experiences (using a 5-point Likert scale 25 ; the survey language was altered to adapt questions to a 5-point Likert scale structure. Unique identifiers were used to link the survey information from before and after the intervention; mean scores on responses were compared between the 2 measurement periods through paired-samples t tests.
Focus groups were conducted at each of the participating practices to solicit feedback on barriers to cancer screening, experiences working with PFs in the intervention, and suggestions for intervention improvement; key informant interviews were conducted when focus groups could not be convened because of practice staff constraints. The participants targeted for inclusion were those identified by the PFs at each practice site as having been most directly involved in the implementation of the project, and they included both clinical providers and administrative staff. The focus groups were hosted at the practice offices, whereas interviews were conducted via a telephone conference call; all focus groups and interviews were conducted by a member of the project leadership team trained in qualitative interviewing techniques. PFs were excluded from any focus group and interview activities pertaining to their assigned practices to reduce bias in participant responses.
All focus groups and interviews were audio-recorded and transcribed verbatim for analysis; no names or other personally identifiable information were recorded in the transcripts. Two members of the project team jointly conducted a thematic content analysis of the transcripts, developing a set of codes based on a list of areas of interest determined a priori: barriers to increasing cancer screening, factors important to the working relationship with the PF, factors important for sustainable change, and feedback on project processes. Discrepancies between the coding schemes were resolved verbally, and the finalized themes and concepts were reviewed by the larger team.
Practice Readiness for Transformation
The TRANSLATE model was used to assess the intervention's impact on key elements of practice transformation. The TRANSLATE model is an assessment tool that measures elements of practice improvement and has been used by researchers conducting similar interventions focused on diabetes care and chronic kidney disease management.
26,27 TRANSLATE stands for "set your Target, use Registry and Reminder systems, get Administrative buy-in, Network information systems, Site coordination, Local Physician Champion, Audit and feedback, Team approach, and Education." 27 Each practice was rated twice by their assigned PF for each of these 9 elementsonce after the initial visit and once at the conclusion of project activities. Each TRANSLATE category was rated on a scale of 1 to 4, with 1 signifying no accomplishment and 4 signifying the highest accomplishment.
PFs received training on the use of the TRANSLATE model before engaging with their practices, including an overview of definitions and a review of practice characteristics meriting each score level. The TRANSLATE assessments were used by PFs as a guide for the work completed with each practice and as a measurement tool for systems-level change within each practice at the conclusion of the project. Practice-level changes in TRANSLATE element scores before and after the intervention and the influence of PF practice groupings were evaluated through a 1-way mixed ANOVA. Spearman correlations were calculated to assess the relationship between both the cancer screening rates and TRANSLATE element scores after the intervention.
Human Subjects Protection
The Institutional Review Board of State University of New York Upstate Medical University determined that this QI project did not meet the definition of human subjects research. All individuals and practices participating in the project were provided information regarding the voluntary nature of participation, and no individually identifiable information was collected.
Results
Intervention Activities
A total of 23 of the 27 primary care practices approached were enrolled in this project. Table 1 summarizes practice characteristics. The majority of practices 16 were located in urban areas, and 2 of these practices hosted primary care resident physicians. Four separate EHR systems were used across the 23 practices. A total of 210 clinical providers attended the ADS at their respective practices; perpractice attendance can be found in Table 1 . The largest group of ADS attendees (37%) was physicians, followed by nurse practitioners, physician assistants, nursing staff, and administrative staff.
The cumulative time devoted to practice facilitation activities by the PFs was approximately 889 hours. Each facilitator was assigned either 5 or 6 practices. Practice facilitation activities included efforts to address documentation procedures for screening referral and completion within practice EHR systems, provider feedback and assessment activities, streamlining of provider reminder systems and office workflows, and patient education and outreach interventions.
Cancer Screening Rates and TRANSLATE Evaluations
The average before-and after-intervention screening rates for the 23 practices can be found in Table  2 . One-way repeated measures ANOVA revealed that the difference between mean screening rates before and after the intervention was statistically significant for breast cancer (36.96% vs 49.96%; P ϭ .001) and CRC (32.74% vs 38.30%; P ϭ .001). There was a wide degree of variation in the cancer screening rates across practices, with standard deviations ranging from roughly 16 to 21 percentage points. The cancer screening rates reported by the practices participating in this project fall, on average, well below the estimated 2014 New York state rates of 68.1% for CRC, 78.6% for breast cancer, and 82.6% for cervical cancer (estimates are based on self-reported data). 28 It is important to note, though, that a small number of practices did meet or exceed the statewide screening rates for each cancer. Individual practice screening rates are not listed here but are available upon request. Table 3 presents the average TRANSLATE model scores before and after the intervention for the 23 practices. The practices, on average, improved in each of the 9 elements measured under the TRANSLATE model. However, it is important to note that, individually, some practices did not make measurable improvements across the 2 measurement periods. One-way mixed ANOVA showed statistically significant improvement in scores for the following elements: setting an improvement target, gaining administrative buy-in, using network information systems, conducting audit and feedback activities, and providing staff education, as well as the overall TRANSLATE score for the practices. Two elements were affected by PF assignments: 1 PF rated practices with a lower score for target, and another PF rated practices with a higher score for education, compared with other PF practice groups. These differences may have been the result of subjective evaluation differences between the PFs or because of the characteristics of the practices evaluated. Spearman correlation results indicated that higher practice scores in site coordinator engagement and staff education were associated with higher cancer screening rates for all 3 cancer Medical group/health system 2-5 Ն2 9
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University hospital/clinic 2-5 Ն2 6 ADS, academic detailing session; FQHC, federally qualified health center; NP, nurse practitioner; PA, physician assistant. targets. In addition, a team approach was positively correlated with cervical cancer screening rates, and administrative buy-in and audit and feedback were positively correlated with CRC screening rates. Results of the correlation analysis are shown in Table 4 .
Staff Surveys and Focus Groups
A total of 144 individuals responded to the staff surveys; of these, only 56 respondents had linked before/after data from the 23 practices. The majority of the nonresponse occurred during the data collection period after the project because of staff turnover and absence at several of the participating practices. The majority of survey respondents were physicians; other respondents included nurse practitioners, physician assistants, registered nurses, licensed practical nurses, and practice/clinic managers. Comparisons of mean responses to Likert-scale questions were conducted only among the 56 linked before/after surveys; most of these differences were not statistically significant. The most important patient-related and system-related barriers to increasing cancer screening as perceived by practice staff centered on a lack of follow-through by patients on screening recommendations and the inability to track patients receiving services at outside offices. Respondents identified the lack of personnel support to both maintain and use registries as among the top barriers to using EHR-based patient registries, and they highlighted provider reminder systems, patient education, and patient reminders as the top QI strategies that would most benefit their practices' ability to increase cancer screening. Focus groups were only conducted in 3 practices, with 3 to 5 individuals participating in each group (a total of 13 participants). Because of scheduling conflicts, key informants were interviewed at the remaining 20 practices. Participants in the 3 focus groups included practice medical directors (n ϭ 3), practice managers (n ϭ 3), care coordinators (n ϭ 2), and clinical providers (n ϭ 5). Key informants were primarily practice managers, practice QI specialists, and practice medical directors.
Content analysis of the focus group and key informant interview transcripts identified several themes related to cancer screening, which fall broadly within the overarching concepts of barriers to increasing cancer screening and supports for increasing cancer screening at the patient, provider, and practice levels. Table 5 displays a breakdown of these concepts. Other common themes that emerged from analysis focused on the working relationship practices had with the PFs, as well as dynamics within practices that supported systemslevel change.
Consistent engagement by the PFs with their site coordinators helped practices keep a focus on QI initiatives, and those practices that experienced the greatest change in both cancer screening rates and policies had fully engaged staff at several levels within the practice. The ADS oriented practice staff to the goals and targets of the project, increasing buy-in for interventions developed later with the PF. Introducing regular provider performance assessment and feedback mechanisms and increas- ing point-of-care reminders and prompts for cancer screening helped clinic staff become more invested in QI projects. Personnel and funding limitations necessitated the implementation of QI project tasks within existing practice structures and priorities, and workflow assessments guided by PFs were viewed as a valuable tool for achieving this end. Several practices chose to overlap project improvement activities with existing requirements and priorities, including patient-centered medical home and meaningful use targets. PFs were also viewed as a valuable resource for connecting practices with patient outreach resources and community services, including mobile mammography providers and transportation services.
All the practices felt that EHR-based reports measuring patient screening rates did not represent accurate data, but rather reflected only those screening tests that were recorded as structured data within their EHRs. PFs were able to provide guidance to practices on altering data entry procedures and support for data mining, data correction, and chart auditing to improve the validity and reliability of EHR registry data used by the practices.
Discussion
The outcomes from this QI project suggest that relatively brief practice facilitation combined with academic detailing may be a useful tool to assist primary care practices in the implementation and augmentation of organizational procedures that lead to increased breast cancer, cervical cancer, and/or CRC screening. However, barriers to increased screening remain at the patient, staff, and organizational levels.
Several factors may have contributed to the low screening rates reported by the participating practices. The practices targeted for participation in this project are considered safety-net practices and provide health care services to underserved populations; the low screening rates reported by our practices may be a reflection of the difficulties experienced by their patients in receiving appropriate preventive care. In addition, all the participating practices felt that EHR-based reports likely underreported the true number of patients receiving appropriate screening because of data storage and retrieval issues.
Participation in this project was beneficial to practices to the extent that it initiated the implementation of evidence-based strategies to increase engagement with patients and interventions resulting in sustainable change, including team-based adaptations to office workflows and policies. Rapidcycle improvements, guided by the project PFs, helped practices make changes to improve screening rates that were tailored to their specific priorities and constraints. Our results further indicate that engagement of the practice site coordinator and provision of educational opportunities for practice staff are particularly important to QI intervention success.
Participation in this project encouraged the initiation of data-mapping activities and efforts to address EHR data recording issues. While participants recognized the potential of EHR-based patient registries to help track and increase patient cancer screening, their current systems and staffing constraints reduced the utility of this tool. The initiation of data entry protocols and data correction procedures laid a foundation for the long-term goals of using reliable and valid clinical data to guide patient care and increasing cancer screening at these practices.
Limitations
Many of the activities initiated during the practice facilitation period will take a substantial amount of time and additional resources to complete, and their impact could not be fully evaluated during the 6-month project period. In addition, the evaluation period may have been too short to capture increased screening for breast cancer and CRC, which often experience a lag between referral and test completion in certain service areas where there are long waiting lists or scheduling delays for specialist providers. The measurement of practice-level screening rates may have been artificially inflated or underestimated based on how practices defined their active patient lists as well as the guidelines used to define screening populations (USPSTF vs American Cancer Society). However, we believe the information provided by the practices is the most accurate picture available of the screening rates they use to guide practice initiatives and patient care, and thus are the most applicable to the aims of the project. The project did not have access to patient-level or provider-level data within the enrolled practices and thus was only able to assess changes in patient screening status for practices as a whole.
The TRANSLATE rubric completed by PFs is a subjective evaluation tool. PFs were provided with training at the initiation of the project to enhance the standardization of the evaluations, but variations between PF perceptions of practice systems may have introduced bias to our findings.
Conclusions
Combining practice facilitation and academic detailing is 1 method through which larger organizations (such as state departments of health) can help practices achieve systems-level changes that enable them to better manage patient population health. An important component of these changes is the optimization of EHR systems: for EHR registry systems to be utilized as tools for improving quality, the data reported must be reliable and valid. 29 The success of projects using this or other, similar methods is also dependent on the provision of adequate time and resources to initiate QI interventions, as well as interest, investment, and dedication to QI by the staff of participating practices.
